Outset Medical (OM) Cash from Financing Activities (2019 - 2026)
Outset Medical (OM) posted quarterly Cash from Financing Activities of $501000.0 for Q1 2026, down 99.1% year-over-year from $55.7 million in Q1 2025, and up 116.88% quarter-over-quarter from $231000.0 in Q3 2025.
Outset Medical (OM) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported Cash from Financing Activities for 8 consecutive years, with $501000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 99.1% year-over-year to $501000.0; the TTM figure through Mar 2026 stood at $348000.0 (down 99.37% YoY), while the FY2025 annual figure was $55.5 million, down 18.22% from the prior year.
- Cash from Financing Activities improved to $501000.0 in Q1 2026 per OM's latest filing, from $231000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $68.6 million in Q1 2024 and bottomed at -$938000.0 in Q4 2024.
- Historically, Cash from Financing Activities has averaged $15.0 million across 5 years, with a median of $1.8 million in 2022.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 6923.55% — and 2025, when it plunged 598.7%.
- Outset Medical's Cash from Financing Activities stood at $65.6 million in 2022, then plunged by 49.35% to $33.2 million in 2023, then sank by 102.82% to -$938000.0 in 2024, then jumped by 124.63% to $231000.0 in 2025, then surged by 116.88% to $501000.0 in 2026.
- Business Quant data shows OM's Cash from Financing Activities at $501000.0 in Q1 2026, $231000.0 in Q3 2025, and -$384000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn | -88,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -88,000.00 |
| Jun 30, 2026 | -88,000.00 |
| Mar 31, 2026 | 501,000.00 |
| Mar 31, 2026 | 501,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Jun 30, 2025 | -384,000.00 |
| Jun 30, 2025 | -384,000.00 |
| Mar 31, 2025 | 55.66 Mn |
| Mar 31, 2025 | 55.66 Mn |
| Dec 31, 2024 | -938,000.00 |
| Dec 31, 2024 | -938,000.00 |
| Sep 30, 2024 | 121,000.00 |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 68.61 Mn |
| Mar 31, 2024 | 68.61 Mn |
| Dec 31, 2023 | 33.23 Mn |
| Dec 31, 2023 | 33.23 Mn |